- Home
- TWST vs EVT Comparison
TWST vs EVT Comparison
Compare TWST & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWST
- EVT
- Stock Information
- Founded
- TWST 2013
- EVT 2003
- Country
- TWST United States
- EVT United States
- Employees
- TWST N/A
- EVT N/A
- Industry
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- EVT Finance Companies
- Sector
- TWST Health Care
- EVT Finance
- Exchange
- TWST Nasdaq
- EVT Nasdaq
- Market Cap
- TWST 2.3B
- EVT 1.9B
- IPO Year
- TWST 2018
- EVT N/A
- Fundamental
- Price
- TWST $31.42
- EVT $24.54
- Analyst Decision
- TWST Buy
- EVT
- Analyst Count
- TWST 9
- EVT 0
- Target Price
- TWST $48.56
- EVT N/A
- AVG Volume (30 Days)
- TWST 1.8M
- EVT 115.5K
- Earning Date
- TWST 11-17-2025
- EVT 01-01-0001
- Dividend Yield
- TWST N/A
- EVT 8.32%
- EPS Growth
- TWST N/A
- EVT N/A
- EPS
- TWST N/A
- EVT 6.63
- Revenue
- TWST $362,273,000.00
- EVT $69,404,302.00
- Revenue This Year
- TWST $22.11
- EVT N/A
- Revenue Next Year
- TWST $17.50
- EVT N/A
- P/E Ratio
- TWST N/A
- EVT $3.55
- Revenue Growth
- TWST 22.72
- EVT N/A
- 52 Week Low
- TWST $24.07
- EVT $19.20
- 52 Week High
- TWST $55.33
- EVT $25.83
- Technical
- Relative Strength Index (RSI)
- TWST 69.28
- EVT 60.30
- Support Level
- TWST $26.20
- EVT $24.41
- Resistance Level
- TWST $33.12
- EVT $24.52
- Average True Range (ATR)
- TWST 1.49
- EVT 0.26
- MACD
- TWST 0.68
- EVT 0.03
- Stochastic Oscillator
- TWST 75.75
- EVT 72.65
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.